Free tool
Device company funding
Last checked: Nov 19, 2026SEC EDGAR Form D data sets and XBRL financial data last updated: Form D through 2026Q3, built 2026-11-19
Companies with SEC financing data
1,843
Of the device makers in our catalog
Private companies with Form D rounds
1,637
5,718 offerings since 2008
Raised in reported rounds
$51.6B
Sum of amounts sold on Form D
Public companies
206
Listed on a US exchange or our curated list
Raised in Form D rounds, by year of first sale
Millions of dollars. Select a year to see companies whose latest round began that year or later.
Private companies by headquarters
From each company's latest Form D.
1,637 private companies
| Company | Raised (Form D) or public float | Latest round | Rounds | Headquarters |
|---|---|---|---|---|
| TheranosPrivate1 FDA device | $627MValuation unknown | Equity$582MMay 15, 2017 | 2 | Palo Alto, California |
| Imperative CarePrivate13 FDA devices | $530MValuation unknown | Convertible note$111MMar 13, 2026 | 5 | Campbell, California |
| Inverness Medical InnovationsPrivate5 FDA devices | $500MValuation unknown | Debt$400MSep 21, 2010 | 2 | Waltham, Massachusetts |
| Auris Surgical RoboticsPrivate2 FDA devices | $464MValuation unknown | Equity$280MApr 5, 2017 | 5 | San Carlos, California |
| HologicPrivate120 FDA devices | $450MValuation unknown | Debt$450MNov 23, 2010 | 1 | Bedford, Massachusetts |
| InsightecPrivate14 FDA devices | $436MValuation unknown | Equity$150MJun 17, 2024 | 3 | Tirat Carmel, Israel |
| Precision NeurosciencePrivate1 FDA device | $422MValuation unknown | Equity$250MSep 11, 2026 | 5 | New York, New York |
| Reflexion MedicalPrivate2 FDA devices | $413MValuation unknown | Equity$107MNov 13, 2023 | 6 | Hayward, California |
| Quantrx BiomedicalPrivate4 FDA devices | $406MValuation unknown | Equity$406MJul 30, 2009 | 1 | Doylestown, PA |
| SetPoint MedicalPrivate1 FDA device | $334MValuation unknown | Equity$115MMar 27, 2025 | 9 | Valencia, California |
| JenaValve TechnologyPrivate1 FDA device | $329MValuation unknown | Equity$100MDec 21, 2021 | 9 | Irvine, California |
| LumicellPrivate1 FDA device | $328MValuation unknown | Equity$198MApr 22, 2025 | 8 | Newton, Massachusetts |
| Impulse DynamicsPrivate3 FDA devices | $312MValuation unknown | Equity$84.1MFeb 20, 2025 | 3 | Dublin 2, Ireland |
| HistoSonicsPrivate2 FDA devices | $308MValuation unknown | Equity$102MJul 31, 2024 | 9 | Plymouth, Minnesota |
| Verily Life SciencesPrivate2 FDA devices | $300MValuation unknown | Equity$300MMar 18, 2026 | 1 | Dallas, Texas |
| GynesonicsPrivate3 FDA devices | $299MValuation unknown | Equity$92.2MApr 6, 2023 | 12 | Redwood City, California |
| Acutus MedicalPrivate9 FDA devices | $292MValuation unknown | Options or warrants$0Jun 30, 2022 | 8 | Carlsbad, California |
| EarlensPrivate2 FDA devices | $282MValuation unknown | Equity$8.0MFeb 19, 2025 | 12 | Menlo Park, California |
| Pear TherapeuticsPrivate3 FDA devices | $255MValuation unknown | Equity$132MDec 7, 2020 | 4 | Boston, Massachusetts |
| ConformisPrivate28 FDA devices | $255MValuation unknown | Options or warrants$0Nov 7, 2014 | 6 | Bedford, Massachusetts |
| BiolinqPrivate1 FDA device | $247MValuation unknown | Equity$90.0MMar 7, 2025 | 8 | San Diego, California |
| Labstyle InnovationsPrivate1 FDA device | $232MValuation unknown | Equity$17.5MSep 22, 2025 | 23 | New York, New York |
| Intrinsic TherapeuticsPrivate4 FDA devices | $219MValuation unknown | Equity$55.5MNov 30, 2023 | 9 | Woburn, Massachusetts |
| Novabay PharmaceuticalsPrivate5 FDA devices | $211MValuation unknown | Options or warrants$134MJan 16, 2026 | 18 | Emeryville, California |
| Route 92 MedicalPrivate8 FDA devices | $208MValuation unknown | Equity$50.0MJan 13, 2026 | 8 | West Jordan, Utah |
| Auris HealthPrivate2 FDA devices | $205MValuation unknown | Equity$205MNov 13, 2018 | 1 | Redwood City, California |
| Relievant MedsystemsPrivate5 FDA devices | $200MValuation unknown | Equity$46.0MMar 20, 2023 | 7 | Edina, Minnesota |
| Personal Genome DiagnosticsPrivate3 FDA devices | $198MValuation unknown | Equity$97.7MFeb 5, 2021 | 8 | Baltimore, Maryland |
| restor3dPrivate14 FDA devices | $197MValuation unknown | Equity$84.8MAug 8, 2025 | 5 | Durham, North Carolina |
| Intuity MedicalPrivate1 FDA device | $196MValuation unknown | Convertible note$26.3MMay 2, 2019 | 11 | Fremont, California |
| EargoPrivate1 FDA device | $187MValuation unknown | Equity$81.6MJul 13, 2020 | 3 | San Jose, California |
| Tmrw Life SciencesPrivate1 FDA device | $185MValuation unknown | Equity$38.4MMar 26, 2026 | 6 | New York, New York |
| SequenomPrivate1 FDA device | $183MValuation unknown | Convertible note$85.0MJun 9, 2015 | 4 | San Diego, United States |
| Ablative SolutionsPrivate1 FDA device | $180MValuation unknown | Equity$10.4MNov 14, 2025 | 14 | Wakefield, Massachusetts |
| Saluda MedicalPrivate3 FDA devices | $180MValuation unknown | Equity$30.0MOct 30, 2025 | 2 | Bloomington, Minnesota |
| MoximedPrivate1 FDA device | $178MValuation unknown | Equity$62.7MAug 7, 2024 | 4 | Fremont, California |
| Vertos MedicalPrivate1 FDA device | $177MValuation unknown | Equity$44.6MMay 22, 2023 | 11 | Aliso Viejo, California |
| Endogastric SolutionsPrivate9 FDA devices | $177MValuation unknown | Equity$27.0MNov 23, 2020 | 10 | Redmond, Washington |
| Swift Health SystemsPrivate1 FDA device | $173MValuation unknown | Equity$102MAug 27, 2021 | 4 | Irvine, California |
| Iterative ScopesPrivate1 FDA device | $172MValuation unknown | Equity$140MDec 6, 2021 | 2 | Cambridge, Massachusetts |
| Exo ImagingPrivate3 FDA devices | $170MValuation unknown | Equity$43.9MMay 28, 2025 | 8 | Santa Clara, California |
| Astute MedicalPrivate1 FDA device | $168MValuation unknown | Equity$43.0MDec 14, 2016 | 11 | San Diego, California |
| Minerva SurgicalPrivate1 FDA device | $167MValuation unknown | Convertible note$15.0MMay 11, 2020 | 13 | Santa Clara, California |
| Cala HealthPrivate5 FDA devices | $166MValuation unknown | Equity$48.2MNov 12, 2024 | 5 | San Mateo, California |
| Akili Interactive LabsPrivate2 FDA devices | $165MValuation unknown | Equity$110MMay 25, 2021 | 2 | Boston, Massachusetts |
| Gt Medical TechnologiesPrivate1 FDA device | $164MValuation unknown | Equity$50.1MMay 8, 2026 | 8 | Tempe, Arizona |
| TransMedicsPrivate7 FDA devices | $162MValuation unknown | Equity$63.7MMay 12, 2016 | 7 | Andover, Massachusetts |
| Apollo EndosurgeryPrivate12 FDA devices | $160MValuation unknown | Equity$25.0MJul 21, 2020 | 7 | Austin, Texas |
| CSA MedicalPrivate4 FDA devices | $160MValuation unknown | Equity$2.9MJun 8, 2026 | 11 | Lexington, Massachusetts |
| CresilonPrivate3 FDA devices | $158MValuation unknown | Convertible note$29.0MApr 24, 2026 | 8 | Brooklyn, New York |
"Private" means not listed on a stock exchange: a company whose last Form D is old may since have been acquired. Companies are matched to SEC filers by name, so a company filing under a different legal name is missed and a different company with the same name can slip in; each company page links to the filings. Form D shows the amount sold so far in an offering, not the final close, and not every round is filed. Public float is the market value of shares held by non-insiders on the date the company reported it, not today's market value. Nothing here is investment advice.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.